Owens & Minor Analyst Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: Ascendis Pharma (ASND), Owens & Minor (OMI) and Illumina (ILMN)
Baird Adjusts Owens & Minor Price Target to $24 From $28, Maintains Neutral Rating
Owens & Minor Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Owens & Minor (OMI), Idexx Laboratories (IDXX) and CytomX Therapeutics (CTMX)
Owens & Minor Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Owens & Minor (OMI), Bruker (BRKR) and Gilead Sciences (GILD)
Owens & Minor Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Owens & Minor (OMI) and Warby Parker (WRBY)
Critical Insights From Owens & Minor Analyst Ratings: What You Need To Know
UBS Adjusts Owens & Minor Price Target to $27 From $26, Maintains Buy Rating
Owens & Minor Analyst Ratings
Maintaining Sell Rating on Owens & Minor: Navigating Short-Term Hurdles While Investing for Long-Term Growth
Owens & Minor Analyst Ratings
UBS Maintains Buy on Owens & Minor, Raises Price Target to $28
Owens & Minor Analyst Ratings
JP Morgan Maintains Underweight on Owens & Minor, Lowers Price Target to $19
Owens & Minor Analyst Ratings
Challenging Outlook and Underperformance Anticipated for Owens & Minor: A Sell Rating Recommendation
Baird Adjusts Owens & Minor's Price Target to $18 From $21, Maintains Neutral Rating